NASDAQ:SMMT

Summit Therapeutics Stock Insider Trading

etoro logo Buy SMMT
*Your capital is at risk
$15.07
+0.210 (+1.41%)
At Close: Jun 03, 2026

Summit Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.90. In total, the insiders bought 136.34M and sold 631.36K SMMT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
99.90
Buy 136.34M shares
Sell 631.36K shares
98% Buy Activity
Weak Positive Correlation
Buy Signal High Confidence
Jun 02, 2026

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 99.9.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming buy-side pressure (98% buys).

Historical Insider Trades

Date Type Person Role Amount
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Ronaghi Mostafa
Director
Director 35 000
Value: $642.3K
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Clark Kenneth A
Director
Director 35 000
Value: $642.3K
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Clark Kenneth A
Director
Director 16 991
Value: $311.8K
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Booth Robert F.
Director
Director 35 000
Value: $642.3K
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Booth Robert F.
Director
Director 6 855
Value: $125.8K
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Booth Robert F.
Director
Director 6 855
Value: $125.8K
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Booth Robert F.
Director
Director 35 000
Value: $642.3K
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Clark Kenneth A
Director
Director 16 991
Value: $311.8K
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Clark Kenneth A
Director
Director 35 000
Value: $642.3K
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Ronaghi Mostafa
Director
Director 35 000
Value: $642.3K
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Cesano Alessandra
Director
Director 3 073
Value: $56.4K
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Cesano Alessandra
Director
Director 35 000
Value: $642.3K
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Xia Yu
Director
Director 5 438
Value: $99.8K
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Xia Yu
Director
Director 35 000
Value: $642.3K
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Huber Jeff
Director
Director 35 000
Value: $642.3K
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Zanganeh Mahkam
Co-chief Executive Officer
CEO / President 10 724
Value: $196.8K
Jan 02, 2025
Buy
Stock Option (right to buy)
A-Award
Duggan Robert W
Co-chief Executive Officer
CEO / President 10 724
Value: $196.8K
Oct 11, 2024
Buy
Stock Option (right to buy)
A-Award
Clark Kenneth A
Director
Director 200 000
Value: $3.99M
Oct 11, 2024
Buy
Stock Option (right to buy)
A-Award
Clark Kenneth A
Director
Director 200 000
Value: $3.99M
Oct 03, 2024
Buy
Common Stock
X-InTheMoney
Zanganeh Mahkam
Co-chief Executive Officer
CEO / President 315 681
Value: $498.8K
Oct 03, 2024
Sell
Warrant (right to buy)
X-InTheMoney
Zanganeh Mahkam
Co-chief Executive Officer
CEO / President 315 681
Value: $498.8K
Oct 03, 2024
Sell
Warrant (right to buy)
X-InTheMoney
Zanganeh Mahkam
Co-chief Executive Officer
CEO / President 315 681
Value: $498.8K
Oct 03, 2024
Buy
Common Stock
X-InTheMoney
Zanganeh Mahkam
Co-chief Executive Officer
CEO / President 315 681
Value: $498.8K
Sep 11, 2024
Buy
Common Stock
A-Award
Zanganeh Mahkam
Co-chief Executive Officer
CEO / President 44 052
Value: $1,000.0K
Sep 11, 2024
Buy
Common Stock
A-Award
Duggan Robert W
Co-chief Executive Officer
CEO / President 3 325 991
Value: $75.5M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT SUMMIT THERAPEUTICS PLC
Summit Therapeutics
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, fo...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE